Charting Disease Trajectories from Isolated REM Sleep Behavior Disorder to Parkinson's Disease
Movement Disorders · 2024-01 · 39 (1) · 64-75
DOI: 10.1002/mds.29662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 25.11.2023. Verfasst von Cécile Di Folco und 9 weiteren Autor:innen. Beteiligte Einrichtung: Inria, Centre de Paris, Paris, France. Hauptthemen laut MEDLINE: REM Sleep Behavior Disorder, Parkinson Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Association France Parkinson, Fondation EDF.
Abstract (Originalsprache)
Background
Clinical presentation and progression dynamics are variable in patients with Parkinson's disease (PD). Disease course mapping is an innovative disease modelling technique that summarizes the range of possible disease trajectories and estimates dimensions related to onset, sequence, and speed of progression of disease markers.
Objective
To propose a disease course map for PD and investigate progression profiles in patients with or without rapid eye movement sleep behavioral disorders (RBD).
Methods
Data of 919 PD patients and 88 isolated RBD patients from three independent longitudinal cohorts were analyzed (follow‐up duration = 5.1; 95% confidence interval, 1.1–8.1] years). Disease course map was estimated by using eight clinical markers (motor and non‐motor symptoms) and four imaging markers (dopaminergic denervation).
Results
PD course map showed that the first changes occurred in the contralateral putamen 13 years before diagnosis, followed by changes in motor symptoms, dysautonomia, sleep—all before diagnosis—and finally cognitive decline at the time of diagnosis. The model showed earlier disease onset, earlier non‐motor and later motor symptoms, more rapid progression of cognitive decline in PD patients with RBD than PD patients without RBD. This pattern was even more pronounced in patients with isolated RBD with early changes in sleep, followed by cognition and non‐motor symptoms and later changes in motor symptoms.
Conclusions
Our findings are consistent with the presence of distinct patterns of progression between patients with and without RBD. Understanding heterogeneity of PD progression is key to decipher the underlying pathophysiology and select homogeneous subgroups of patients for precision medicine. © 2023 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inria, Centre de Paris, Paris, France.
- Paris Brain Institute-ICM, Paris, France.
- Inserm, Paris, France.
- CNRS, Paris, France.
- Sorbonne Université, Paris, France.
- AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France.
ORCID-Profile: Isabelle Arnulf, Pauline Dodet, Marie Vidailhet, Jean-Christophe Corvol, Stanley Durrleman
Förderung
- Agence Nationale de la Recherche
- Association France Parkinson
- Fondation EDF
- H2020 European Research Council
- H2020 Health
Zitieren
APA
Di Folco, C., Couronné, R., Arnulf, I., Mangone, G., Leu-Semenescu, S., Dodet, P., Vidailhet, M., Corvol, J. C., Lehéricy, S., & Durrleman, S. (2024). Charting Disease Trajectories from Isolated REM Sleep Behavior Disorder to Parkinson's Disease. Movement Disorders, 39(1), 64-75. https://doi.org/10.1002/mds.29662
Vancouver
Di Folco C, Couronné R, Arnulf I, Mangone G, Leu-Semenescu S, Dodet P, et al. Charting Disease Trajectories from Isolated REM Sleep Behavior Disorder to Parkinson's Disease. Movement Disorders. 2024;39(1):64-75. doi:10.1002/mds.29662
BibTeX
@article{DiFolco2024,
author = {Di Folco, Cécile and Couronné, Raphaël and Arnulf, Isabelle and Mangone, Graziella and Leu-Semenescu, Smaranda and Dodet, Pauline and Vidailhet, Marie and Corvol, Jean-Christophe and Lehéricy, Stéphane and Durrleman, Stanley},
title = {Charting Disease Trajectories from Isolated REM Sleep Behavior Disorder to Parkinson's Disease},
journal = {Movement Disorders},
year = {2024},
volume = {39},
number = {1},
pages = {64--75},
doi = {10.1002/mds.29662}
}
EUVIMED